Phase I/II study of sagopilone (ZK-EPO) plus carboplatin in women with recurrent platinum-sensitive ovarian cancer

BACKGROUND: Sagopilone is the first fully synthetic epothilone in clinical development and has demonstrated promising preclinical activity. This phase I/II, prospective, open-label trial investigated the efficacy and safety of sagopilone plus carboplatin in patients with recurrent platinum-sensitive...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: McMeekin, S, Patel, R, Verschraegen, C, Celano, P, Burke, J, Plaxe, S, Ghatage, P, Giurescu, M, Stredder, C, Wang, Y, Schmelter, T
Natura: Artigo
Lingua:Inglês
Pubblicazione: Nature Publishing Group 2012
Soggetti:
Clinical Study
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3251849/
https://ncbi.nlm.nih.gov/pubmed/22108514
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2011.499
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi